Stocks traded mixed on Tuesday after U.S. federal health officials called for a pause in the rollout of Johnson & Johnson's (JNJ) COVID-19 vaccine amid concerns over rare blood clots in some individuals who received the inoculation.
The stay-at-home stocks quickly came back into favor on news of a setback with Johnson & Johnson's single-dose COVID-19 vaccine.
Tuesday was a mixed day for the stock market, but the Nasdaq Composite (NASDAQINDEX: ^IXIC) came out on top by midafternoon. The Nasdaq was up two-thirds of a percent as of 1:30 p.m. EDT today even as some other major market benchmarks remained down on the day. Investors were surprised in 2020 when the Nasdaq was able to mount such a huge gain even during the worst of the pandemic.